PPARG and cancer: The unilateral effect of the PPARγ rs1801282 variant was not statistically significantly linked to the cancer risk (OR (95% CI) = 0.932 (0.830–1.046), P = 0.865), although NSAID usage unilaterally reduced this risk by a significant level (OR (95% CI) = 0.743 (0.673–0.820), P < 0.001) (Table 6).